Page last updated: 2024-10-22

altretamine and Hodgkin Disease

altretamine has been researched along with Hodgkin Disease in 2 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borden, EC1
Larson, P1
Ansfield, FJ1
Bryan, GT1
Johnson, RO1
Ramirez, G1
Wilson, WL1
Budman, DR1
Anderson, J1
Obrecht, JP1
Canellos, GP1
Creaven, P1
Norton, L1
Gottlieb, A1

Other Studies

2 other studies available for altretamine and Hodgkin Disease

ArticleYear
Hexamethylmelamine treatment of sarcomas and lymphomas.
    Medical and pediatric oncology, 1977, Volume: 3, Issue:4

    Topics: Adolescent; Adult; Altretamine; Bone Marrow; Bone Neoplasms; Child; Digestive System; Female; Hodgki

1977
Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171.
    Cancer treatment reports, 1985, Volume: 69, Issue:6

    Topics: Adult; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Hodgkin Disea

1985